SEEL logo

Seelos Therapeutics (SEEL) Current Assets

Annual Current Assets

$5.40 M
-$17.27 M-76.17%

31 December 2023

SEEL Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$2.33 M
-$1.22 M-34.25%

30 June 2024

SEEL Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SEEL Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-76.2%-62.3%
3 y3 years-69.1%-97.1%
5 y5 years+46.6%-85.6%

SEEL Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-93.5%at low-97.2%at low
5 y5 years-93.5%+46.6%-97.4%at low
alltimeall time-93.5%+2569.5%-97.4%+183.6%

Seelos Therapeutics Current Assets History

DateAnnualQuarterly
June 2024
-
$2.33 M(-34.3%)
Mar 2024
-
$3.55 M(-34.3%)
Dec 2023
$15.00 K(-79.2%)
$5.40 M(-12.7%)
Sept 2023
-
$6.19 M(-47.8%)
June 2023
-
$11.85 M(-49.8%)
Mar 2023
-
$23.58 M(+4.0%)
Dec 2022
$72.00 K(+84.6%)
$22.67 M(-44.0%)
Sept 2022
-
$40.51 M(-23.1%)
June 2022
-
$52.65 M(-25.5%)
Mar 2022
-
$70.67 M(-15.3%)
Dec 2021
$39.00 K(>+9900.0%)
$83.46 M(+3.2%)
Sept 2021
-
$80.89 M(-10.4%)
June 2021
-
$90.25 M(+118.5%)
Mar 2021
-
$41.30 M(+136.1%)
Dec 2020
$0.00(0.0%)
$17.49 M(+77.1%)
Sept 2020
-
$9.88 M(+27.3%)
June 2020
-
$7.76 M(-45.2%)
Mar 2020
-
$14.17 M(+27.7%)
Dec 2019
$0.00(-100.0%)
$11.10 M(-31.6%)
Sept 2019
-
$16.21 M(+58.1%)
June 2019
-
$10.26 M(-16.8%)
Mar 2019
-
$12.32 M(+234.3%)
Dec 2018
$75.00 K(-34.2%)
$3.69 M(-32.8%)
Sept 2018
-
$5.48 M(-23.1%)
June 2018
-
$7.13 M(+20.5%)
Mar 2018
-
$5.92 M(-10.2%)
Dec 2017
$114.00 K(-89.3%)
$6.59 M(-24.1%)
Sept 2017
-
$8.69 M(+0.5%)
June 2017
-
$8.65 M(+68.1%)
Mar 2017
-
$5.15 M(+41.6%)
Dec 2016
$1.07 M(-31.8%)
$3.63 M(-49.8%)
Sept 2016
-
$7.24 M(+46.9%)
June 2016
-
$4.92 M(-46.0%)
Mar 2016
-
$9.12 M(+46.7%)
Dec 2015
$1.56 M(+2.9%)
$6.22 M(-23.9%)
Sept 2015
-
$8.16 M(-16.8%)
June 2015
-
$9.82 M(-45.6%)
Mar 2015
-
$18.04 M(+35.7%)
Dec 2014
$1.52 M(+45.3%)
$13.29 M(-27.7%)
Sept 2014
-
$18.37 M(-2.5%)
June 2014
-
$18.83 M(-20.0%)
Mar 2014
-
$23.54 M(+5.7%)
Dec 2013
$1.05 M(-64.9%)
$22.26 M(+2.8%)
Sept 2013
-
$21.66 M(-17.7%)
June 2013
-
$26.32 M(+68.9%)
Mar 2013
-
$15.58 M(-25.4%)
Dec 2012
$2.98 M(-64.6%)
$20.89 M(-21.9%)
Sept 2012
-
$26.75 M(+35.5%)
June 2012
-
$19.74 M(-14.6%)
Mar 2012
-
$23.13 M(+182.3%)
DateAnnualQuarterly
Dec 2011
$8.42 M(+0.4%)
$8.19 M(-12.4%)
Sept 2011
-
$9.35 M(-0.1%)
June 2011
-
$9.36 M(-18.0%)
Mar 2011
-
$11.42 M(+9.0%)
Dec 2010
$8.39 M(-56.2%)
$10.48 M(+251.6%)
Sept 2010
-
$2.98 M(-41.7%)
June 2010
-
$5.11 M(+56.3%)
Mar 2010
-
$3.27 M(+85.2%)
Dec 2009
$19.17 M(+241.6%)
$1.77 M(+7.1%)
Sept 2009
-
$1.65 M(-44.3%)
June 2009
-
$2.96 M(-27.0%)
Mar 2009
-
$4.05 M(+37.6%)
Dec 2008
$5.61 M(-19.7%)
$2.95 M(+74.7%)
Sept 2008
-
$1.69 M(-54.7%)
June 2008
-
$3.73 M(+45.2%)
Mar 2008
-
$2.57 M(-30.3%)
Dec 2007
$6.99 M(-6.6%)
$3.68 M(-10.4%)
Sept 2007
-
$4.11 M(-30.0%)
June 2007
-
$5.87 M(-46.0%)
Mar 2007
-
$10.88 M(-12.6%)
Dec 2006
$7.49 M(-16.0%)
$12.45 M(+90.9%)
Sept 2006
-
$6.52 M(-17.1%)
June 2006
-
$7.86 M(-13.3%)
Mar 2006
-
$9.07 M(+105.3%)
Dec 2005
$8.91 M(-8.5%)
$4.42 M(-45.7%)
Sept 2005
-
$8.14 M(+35.8%)
June 2005
-
$5.99 M(+3.8%)
Mar 2005
-
$5.77 M(-45.2%)
Dec 2004
$9.74 M(-8.3%)
$10.53 M(+34.2%)
Sept 2004
-
$7.85 M(-39.0%)
June 2004
-
$12.86 M(+45.8%)
Mar 2004
-
$8.82 M(-29.5%)
Dec 2003
$10.62 M(-10.5%)
$12.51 M(+35.9%)
Sept 2003
-
$9.21 M(+304.0%)
June 2003
-
$2.28 M(+176.9%)
Mar 2003
-
$822.90 K(-63.8%)
Dec 2002
$11.87 M(+54.3%)
$2.27 M(-65.6%)
Sept 2002
-
$6.60 M(-52.9%)
June 2002
-
$14.01 M(+19.9%)
Mar 2002
-
$11.69 M(-40.4%)
Dec 2001
$7.69 M(+126.4%)
$19.62 M(-24.2%)
Sept 2001
-
$25.89 M(-9.9%)
June 2001
-
$28.75 M(-13.3%)
Mar 2001
-
$33.15 M(-9.4%)
Dec 2000
$3.40 M(+1032.4%)
$36.59 M(-11.0%)
Sept 2000
-
$41.13 M(+126.6%)
June 2000
-
$18.15 M(+53.1%)
Mar 2000
-
$11.85 M
Dec 1999
$300.00 K(-85.9%)
-
Dec 1997
$2.13 M
-

FAQ

  • What is Seelos Therapeutics annual total current assets?
  • What is the all time high annual current assets for Seelos Therapeutics?
  • What is Seelos Therapeutics annual current assets year-on-year change?
  • What is Seelos Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly current assets year-on-year change?

What is Seelos Therapeutics annual total current assets?

The current annual current assets of SEEL is $5.40 M

What is the all time high annual current assets for Seelos Therapeutics?

Seelos Therapeutics all-time high annual total current assets is $83.46 M

What is Seelos Therapeutics annual current assets year-on-year change?

Over the past year, SEEL annual total current assets has changed by -$17.27 M (-76.17%)

What is Seelos Therapeutics quarterly total current assets?

The current quarterly current assets of SEEL is $2.33 M

What is the all time high quarterly current assets for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly total current assets is $90.25 M

What is Seelos Therapeutics quarterly current assets year-on-year change?

Over the past year, SEEL quarterly total current assets has changed by -$3.85 M (-62.28%)